BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8887463)

  • 1. Effects of cadmium on osteoclast formation and activity in vitro.
    Wilson AK; Cerny EA; Smith BD; Wagh A; Bhattacharyya MH
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):451-60. PubMed ID: 8887463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
    Lees RL; Heersche JN
    J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
    Kaji H; Sugimoto T; Kanatani M; Chihara K
    J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S 12911-2 inhibits osteoclastic bone resorption in vitro.
    Takahashi N; Sasaki T; Tsouderos Y; Suda T
    J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
    Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
    J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
    Yates AJ; Oreffo RO; Mayor K; Mundy GR
    J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
    de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
    J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
    Yamaguchi M; Uchiyama S
    J Cell Biochem; 2005 Mar; 94(4):794-803. PubMed ID: 15578574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ethanol on bone cells in vitro resulting in increased resorption.
    Cheung RC; Gray C; Boyde A; Jones SJ
    Bone; 1995 Jan; 16(1):143-7. PubMed ID: 7742073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
    Huang J; Yuan L; Wang X; Zhang TL; Wang K
    Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation.
    Ilvesaro JM; Lakkakorpi PT; Väänänen HK
    Exp Cell Res; 1998 Jul; 242(1):75-83. PubMed ID: 9665804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S; Yamaguchi M
    Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of medium acidification by alteration of carbon dioxide or bicarbonate concentrations on the resorptive activity of rat osteoclasts.
    Arnett TR; Boyde A; Jones SJ; Taylor ML
    J Bone Miner Res; 1994 Mar; 9(3):375-9. PubMed ID: 8191931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
    Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
    In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.